/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN
THE UNITED STATES/
VANCOUVER, March 7, 2017 /CNW/ - Winston Resources Inc.
("Winston" or the "Company") (CSE: WRW; FSE:WNT) is pleased to announce in conjunction with its proposed
acquisition of Green Tree Therapeutics, the Company has appointed Mr. Gordon Jang, as chairman of
the company's advisory board. The advisory board will enhance the Company's ability to bring in tactical growth partnerships
through strategic investments which is an important part of the company's approach to capture sales and the newest developing
technologies in the cannabinoid sector.
Mr. Jang brings more than 25 years' experience in the mining industry and has extensive knowledge of Sarbanes-Oxley, internal
controls, mergers and acquisitions, tax planning, and regulatory compliance matters.
Mr. Jang has worked with Lundin Mining Corporation, Augusta Resources Corporation, Hudbay Minerals Inc and Pan American Silver
Corp. In various roles ranging from Corporate Controller to Vice President. He is a graduate of the British Columbia Institute of
Technology's Financial Management program and holds a CPA, CMA designation.
Mr. Jang brings invaluable experience, expertise and insight, and the company looks forward to developing numerous growth
strategies. Mr. Jang will be granted options at a later date, subject to approval by the Canadian Securities Exchange.
Update on Proposed Transaction
On February 24, 2017 Winston signed a Letter of Intent (the "LOI") with GT Therapeutics
Corporation, dba Green Tree Therapeutics, an arm's length private British Columbia company (the
"Target" or "GTT"), pursuant to which the Company will complete a reverse takeover and acquire from the
shareholders of the Target, 100% of the shares of GTT, causing GTT to become a wholly owned subsidiary of Winston (the
"Transaction"). On completion of the Transaction, the business of the Target will become the business of Winston and
the Company will abandon the Pigeon River property.
The Company continues to work through due diligence and negotiation of the definitive agreement. The Transaction remains
subject to certain closing conditions, including, completion of due diligence, the negotiation and signing of a definitive
agreement and obtaining all necessary approvals, including, approval of the respective boards, the approval of the Canadian
Securities Exchange (the "CSE"), and if applicable, shareholders of the Company. There can be no guarantees that the
Transaction will be completed as proposed or at all.
About Green Tree Therapeutics
Green Tree Therapeutics ("GTT") owns a brand of vaporizers currently in 130 stores, including medical and adult use
dispensaries across North America, and is actively engaged in the expansion of its product
offerings for alternate cannabis products, including capsules, oils, and lotions. GTT's vaporizers provide therapeutic
benefits in the delivery of beneficial CBD and THC extracts, and a system for rapid absorption for the quick delivery of
cannabinoids. Further information can be found on the Company's website at www.greentreetherapeutics.com.
ON BEHALF OF THE BOARD OF DIRECTORS
"Shawn Bromley"
Shawn Bromley,
Chief Executive Officer
Cautionary Statement Regarding "Forward-Looking" Information
The forward-looking information contained in this press release is made as of the date of this press release and, except as
required by applicable law, the Company does not undertake any obligation to update publicly or to revise any of the included
forward-looking information, whether as a result of new information, future events or otherwise, except as may be required by
law. By its very nature, such forward-looking information requires the Company to make assumptions that may not materialize or
that may not be accurate. This forward-looking information is subject to known and unknown risks and uncertainties and other
factors, which may cause actual results, levels of activity and achievements to differ materially from those expressed or implied
by such information.
SOURCE Winston Resources
To view the original version on PR Newswire, visit: http://www.newswire.ca/en/releases/archive/March2017/07/c1102.html